SCHEMBL23242992

SCHEMBL23242992

Cc1cccc(C)c1/N=N/c1c(C)cccc1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.68
▸ MEN1 O00255 2/20 0.68
▸ KMT2A Q03164 2/20 0.68
▸ HSP90AA1 P07900 1/20 0.68
▸ CYP2A6 P11509 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ ACHE P22303 3/20 0.47
▸ TSHR P16473 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA7 P43166 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ GRIN2D O15399 2/20 0.41
▸ GRIN3B O60391 2/20 0.41
▸ GRIN1 Q05586 2/20 0.41
▸ GRIN2A Q12879 2/20 0.41
▸ GRIN2B Q13224 2/20 0.41
▸ GRIN2C Q14957 2/20 0.41
▸ GRIN3A Q8TCU5 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10480070 1.00 ATM (0.68) ATMMEN1KMT2AHSP90AA1CYP2A6
SCHEMBL11224625 0.85 ATM (0.54) ATMMEN1KMT2AHSP90AA1CYP2A6
SCHEMBL11224623 0.85 ATM (0.54) ATMMEN1KMT2AHSP90AA1CYP2A6
SCHEMBL16594280 0.84 ALDH1A1 (0.57) ATMMEN1KMT2AHSP90AA1ACHE
SCHEMBL16594278 0.84 ALDH1A1 (0.57) ATMMEN1KMT2AHSP90AA1ACHE
SCHEMBL19336625 0.83 ATM (0.52) ATMMEN1KMT2AHSP90AA1CYP2A6
Dimethylamine SCHEMBL3693873 0.83 MEN1 (0.52) ATMMEN1KMT2AHSP90AA1CYP2A6
SCHEMBL11151430 0.79 MEN1 (0.64) ATMMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL11151415 0.79 MEN1 (0.64) ATMMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL7937665 0.79 ATM (0.48) ATMMEN1KMT2AHSP90AA1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108997139-B Synthetic method of 3,3',5,5' -tetramethyl benzidine and hydrochloride thereof 南京艾普特生物医药有限公司 2020-11-10 — — CN claimed
CN-108997139-A A kind of synthetic method of 3,3`, 5,5`- tetramethyl benzidine and its hydrochloride 南京艾普特生物医药有限公司 2018-12-14 — — CN claimed
US-11028044-B2 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3′5,5′-tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays SLR Biosciences, LLC (US) 2021-06-08 — — US disclosed
US-11028044-B2 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3′5,5′-tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays SLR Biosciences, LLC (US) 2021-06-08 — — US disclosed
US-20210114974-A1 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3'5,5'-Tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays SLR Biosciences, LLC (US) 2021-04-22 — — US disclosed
US-20210114974-A1 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3'5,5'-Tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays SLR Biosciences, LLC (US) 2021-04-22 — — US disclosed
CN-108997139-B Synthetic method of 3,3',5,5' -tetramethyl benzidine and hydrochloride thereof 南京艾普特生物医药有限公司 2020-11-10 — — CN disclosed
CN-108997139-A A kind of synthetic method of 3,3`, 5,5`- tetramethyl benzidine and its hydrochloride 南京艾普特生物医药有限公司 2018-12-14 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210114974-A1 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3'5,5'-Tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays BTD, MPO, TPO ATM 2008/4885MEN1 1983/4885KMT2A 3254/4885
US-11028044-B2 Versatile, concise and convenient process for the commercial scale preparation of highest pure 3,3′5,5′-tetramethylbenzidine (TMB) and its salts, a chromogenic substrate used in staining procedures in immunohistochemistry and visualizing reagent in enzyme-linked immunosorbent assays BTD, MPO, TPO ATM 1963/4885MEN1 2017/4885KMT2A 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback